Shameless Cloning: Mohnish Pabrai’s Genius Strategy of Copying the Best Investors — Why Original Thinking Is Overrated and How Indian Investors Can Build Wealth by Legally Stealing Ideas from Superinvestors

The Most Counterintuitive Idea in Investing: Stop Trying to Be Original

Every aspiring investor dreams of discovering the next multibagger before anyone else — the hidden gem buried in annual reports, the contrarian bet no one sees coming. We romanticize the lone genius who outsmarts the market with a flash of brilliant, original insight.

But what if the path to extraordinary returns isn’t through originality at all? What if the smartest thing you can do is shamelessly copy investors who are already beating the market?

That’s exactly what Mohnish Pabrai — one of the most successful value investors of the last two decades — has been preaching and practicing through his concept of “Shameless Cloning.” And the data behind this strategy is staggering.

With the Indian markets navigating volatility (the Nifty 50 closed near 22,700 on April 2, 2026, ahead of the Good Friday holiday), and individual investors desperately searching for an edge, Pabrai’s Shameless Cloning framework offers a powerful, evidence-based alternative to the gamble of trying to outsmart the market alone.

What Exactly Is Shameless Cloning?

Shameless Cloning is the deliberate, disciplined practice of studying the disclosed portfolios of proven superinvestors and replicating their highest-conviction stock picks. It is not passive mimicry — it is strategic leveraging of freely available regulatory disclosures to ride the coattails of investing legends.

Pabrai’s philosophy is rooted in a simple, powerful truth: the best investors in the world are required by law to disclose their holdings. In the United States, the SEC mandates that institutional investors managing over $100 million file quarterly 13F reports revealing their complete equity positions. In India, SEBI requires disclosure of bulk and block deals, mutual fund portfolios, and promoter shareholding changes.

This means the homework of Buffett, Munger, and dozens of other superinvestors is available to you — for free. Pabrai calls it the greatest free lunch in investing.

The Chain of Cloning: From Graham to Buffett to Pabrai

Here’s what most people miss about investing history: every legendary investor was a shameless cloner at some point.

Warren Buffett didn’t invent value investing — he cloned Benjamin Graham’s principles, then evolved them with Philip Fisher’s growth insights and Charlie Munger’s focus on quality businesses. Munger himself cloned Fisher’s scuttlebutt method. Chuck Akre cloned Buffett’s approach to compounders. And Mohnish Pabrai openly admits he built his entire investment framework by studying and copying what Buffett, Munger, and Graham did right.

The lesson? Originality is overrated. Execution and discipline are everything. The greatest investors don’t succeed because they invented a new method — they succeed because they found what works and applied it relentlessly.

The Academic Proof: Cloning Buffett Beat the S&P 500 by 10.75% Annually for 30 Years

In 2008, a landmark academic study by Professor Gerald Martin and researcher John Puthenpurackal tested a simple hypothesis: What if you just copied Warren Buffett’s disclosed portfolio with a significant time delay?

The results were remarkable. A portfolio that simply cloned Buffett’s 13F filings from 1976 to 2006 — with the inherent 45-day reporting delay — beat the S&P 500 by approximately 10.75% annually over 30 years. This was despite the cloner always being at least six weeks behind Buffett’s actual trades.

Think about that: even a delayed, imperfect copy of a superinvestor’s portfolio crushed the market over three decades. If a simple copy can generate that kind of alpha, imagine what a thoughtful, disciplined cloning strategy can achieve.

How Pabrai Built His “Shameless Portfolio”

Pabrai didn’t just preach cloning — he systematized it. Working with quantitative analyst Fei Li, he created a structured “Shameless Portfolio” with precise rules.

The system draws from nine carefully selected value-oriented investment managers, including firms like Berkshire Hathaway, Fairfax Financial, Greenlight Capital, Markel Corporation, ValueAct Capital, and Pabrai’s own fund. Each manager’s highest-conviction picks are selected using an ingenious mathematical method based on the digits of Pi, eliminating human bias from the selection process entirely.

The rules are elegant in their simplicity: one stock per manager, no REITs or utilities, no unprofitable companies, annual rebalancing with no mid-year adjustments. The last digit of Pi used in one year becomes the starting point for the next — creating a perpetual, bias-free selection machine.

The result? Over a 16-year test period from 2000 to 2017, the Shameless Cloned Portfolio beat the S&P 500 by 10.7% annually and generated a cumulative return 953.8% higher than the index. This period included the dot-com crash, the 2008 Global Financial Crisis, and multiple bear markets — yet the cloning strategy delivered extraordinary outperformance.

The 5-Step Shameless Cloning Framework for Indian Investors

While Pabrai’s original framework focused on US 13F filings, Indian investors have their own rich set of regulatory disclosures to leverage. Here’s how to apply Shameless Cloning to the Indian stock market:

Step 1: Identify Your Superinvestor Panel. Select 5-8 proven Indian value investors or fund managers with verifiable long-term track records. Look at SEBI-registered portfolio managers, successful fund houses, and well-known individual investors whose holdings are publicly tracked. Study their investment philosophy to ensure they are genuine long-term value investors, not momentum traders.

Step 2: Monitor Their Disclosed Holdings Religiously. In India, mutual fund portfolios are disclosed monthly. Bulk and block deal data is published daily by BSE and NSE. Shareholding patterns (including promoter, FII, and DII holdings) are disclosed quarterly. Use platforms like Trendlyne, Screener.in, and Tijori Finance to track these disclosures systematically.

Step 3: Identify High-Conviction New Positions. The most valuable cloning signals are new positions — when a superinvestor initiates a fresh stake in a company. This is far more meaningful than an existing holding being marginally increased. Look for positions that represent a significant percentage of the manager’s portfolio, indicating high conviction.

Step 4: Do Your Own Due Diligence — Clone the Position, Not the Blindness. This is where Pabrai’s approach differs from mindless copying. Use the superinvestor’s pick as a starting point for your own research. Verify the company’s fundamentals — check ROCE, debt levels, promoter quality, and cash flow sustainability. A cloned idea that you’ve independently validated becomes a high-confidence investment.

Step 5: Hold with Discipline. If you’ve cloned from a superinvestor who is a long-term holder, don’t panic-sell at the first drawdown. The academic evidence shows that cloning works precisely because it enforces patience — you’re riding the conviction of someone who has done thousands of hours of research.

Real-World Indian Example: The Power of Cloning Quality

Consider how this principle applies to quality Indian small-caps. Take Titan Biotech Ltd (BSE: 524717), currently trading at Rs 504 with a market capitalization of Rs 2,082 crore. The company boasts a ROCE of 16.9% and ROE of 15.0% — classic hallmarks of a quality business that generates returns well above its cost of capital.

If a proven investor with a track record of identifying quality small-caps initiated a position in a company like this, a shameless cloner would take notice — then dig into the financial statements, verify the capital efficiency metrics, check the management quality, and then make an informed decision. The clone provides the idea; your own analysis provides the conviction.

This is exactly how Pabrai operates: the initial idea may come from someone else, but the final investment decision is backed by independent work.

Why Most Investors Refuse to Clone — And Why That’s Your Edge

Despite the overwhelming evidence, most investors resist cloning. Why? Three deeply human biases work against it:

The Ego Barrier: We want to feel smart. Telling people “I copied this idea from a superinvestor” feels intellectually inferior to “I discovered this hidden gem through my own analysis.” But investing isn’t about feeling smart — it’s about making money. Pabrai has been clear: he would rather be rich and seen as unoriginal than be broke and celebrated for his creative thinking.

The Not-Invented-Here Syndrome: Psychologically, we overvalue ideas that originate from ourselves and undervalue those that come from others. This cognitive bias causes investors to dismiss perfectly good cloned ideas while chasing mediocre ideas of their own creation.

The Illusion of Complexity: Many investors believe that making money in markets requires complex algorithms, proprietary data, or sophisticated quantitative models. Cloning seems “too simple.” But simplicity is not the same as simplistic — it takes genuine discipline to identify the right investors to clone, monitor their filings systematically, and hold positions with patience.

The beauty of this bias is that it creates a structural advantage for shameless cloners. Because most people refuse to clone, the strategy remains underexploited despite being freely available to everyone.

Cloning vs. F&O Gambling: A Reality Check

While shameless cloning produces long-term wealth through disciplined equity investing, millions of Indian retail investors are doing the exact opposite — gambling in Futures and Options. SEBI’s own study confirms that 9 out of 10 individual traders in the F&O segment incur net losses.

The contrast is stark: cloning superinvestors has been academically proven to beat the market by over 10% annually for decades, while F&O trading destroys wealth for 90% of participants. One approach requires patience and humility; the other feeds on ego, adrenaline, and the illusion of quick riches.

If you’re currently spending hours analyzing option chains and futures premiums, ask yourself: Would you achieve better results by spending that time tracking what the best equity investors in the world are buying?

Building Your Own Shameless Cloning System: A Practical Checklist

To get started with Shameless Cloning in the Indian market context, here is a practical framework you can implement immediately:

First, create a watchlist of 5-8 proven superinvestors whose regulatory filings you can track. Second, set up alerts for bulk/block deals and quarterly shareholding pattern disclosures. Third, when a superinvestor initiates a new position, add it to your research pipeline — do not buy immediately. Fourth, conduct your own fundamental analysis using tools like Screener.in (check ROCE, debt-to-equity, cash flow, promoter holding trends). Fifth, if your independent analysis confirms the quality thesis, build your position gradually. Sixth, hold with conviction for at least 2-3 years — cloning works on long timeframes, not on quarterly trading. Seventh, review and rebalance annually, checking whether the superinvestors you’re tracking are still holding their positions.

This systematic approach transforms cloning from casual stock-tip following into a rigorous, repeatable investment process.

The Bottom Line: Stand on the Shoulders of Giants

Mohnish Pabrai’s Shameless Cloning concept is one of the most powerful yet underutilized strategies in value investing. It works because it combines the expertise of proven superinvestors with the discipline of systematic implementation — and it eliminates the ego-driven mistakes that destroy most individual portfolios.

The evidence is clear: a cloned portfolio of superinvestor picks beat the S&P 500 by over 10% annually for 30 years. In a world where most professional fund managers fail to beat their benchmarks, that kind of edge is extraordinary.

For Indian investors navigating today’s volatile markets, the message is simple: stop trying to reinvent the wheel. Find investors who have already built the wheel, study their blueprints, and build your own — shamelessly.

As Pabrai himself says: there is such a thing as a free lunch in investing. The superinvestors are serving it to you four times a year through their mandatory disclosures. All you have to do is show up to the table.

Start your value investing education journey with our free course: Value Investing Course Playlist

SEBI Disclaimer: 9 out of 10 individual traders in the equity Futures & Options segment incurred net losses according to a SEBI study. F&O trading is essentially gambling. Focus on quality stock picking and long-term value investing instead.

Disclaimer: The author (Manish Goel) is a SEBI Registered Research Analyst (Registration No. INH100004775) and Multibagger Shares (Multibagger Securities Research & Advisory Pvt. Ltd.) is a SEBI Registered Investment Advisor (Registration No. INA100007736). This post is for educational purposes only and should not be construed as a buy/sell recommendation. Please do your own research and consult a qualified financial advisor before making investment decisions. Stock market investments are subject to market risks. Past performance is not indicative of future results.

Manish Goel

Manish Goel is a Chartered Accountant, SEBI-registered Investment Advisor, and founder of Multibagger Shares. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

See Full Bio